Altogether, the different clinical phenotypes reported in patients with anti-septin-3, anti-septin-5 or anti-septin-7 autoimmunity so far suggest that these autoantibodies may be markers for different clinical presentations. This evidence concerns the gene SEPTIN5 and Autoimmunity.